标题
Optimizing oncolytic virotherapy in cancer treatment
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-10
DOI
10.1038/s41573-019-0029-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Checkpoint inhibitors go viral
- (2019) Melanie Senior NATURE BIOTECHNOLOGY
- Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
- (2018) John A. Barrett et al. CANCER GENE THERAPY
- Armed oncolytic viruses: A kick-start for anti-tumor immunity
- (2018) J.F. de Graaf et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer immunotherapy beyond immune checkpoint inhibitors
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
- (2018) Jacob P. van Vloten et al. JOURNAL OF IMMUNOLOGY
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
- (2018) Nikolas Tim Martin et al. MOLECULAR THERAPY
- Superagonist IL-15-armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
- (2018) Stacy J. Kowalsky et al. MOLECULAR THERAPY
- Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
- (2018) Jacob M. Ricca et al. MOLECULAR THERAPY
- MicroRNA-Regulated Gene Delivery Systems for Research and Therapeutic Purposes
- (2018) Bijay Dhungel et al. MOLECULES
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition
- (2018) Mohammed Selman et al. Science Translational Medicine
- Genomics and emerging biomarkers for immunotherapy of colorectal cancer
- (2018) Jakob Nikolas Kather et al. SEMINARS IN CANCER BIOLOGY
- A Recombinant Antibody-Expressing Influenza Virus Delays Tumor Growth in a Mouse Model
- (2018) Jennifer R. Hamilton et al. Cell Reports
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies
- (2018) Shashi Gujar et al. OncoImmunology
- Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
- (2018) Mathias Felix Leber et al. Molecular Therapy-Oncolytics
- STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
- (2018) Abdi Ghaffari et al. BRITISH JOURNAL OF CANCER
- Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study.
- (2018) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and preliminary efficacy of talimogene laherparepvec (T-VEC) in combination (combo) with pembrobrolizumab (Pembro) in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC): A multicenter, phase 1b study (MASTERKEY-232).
- (2018) Kevin J. Harrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
- (2018) Tarsila Mendes de Camargo et al. Scientific Reports
- Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment
- (2018) Amanda Rosewell Shaw et al. Frontiers in Immunology
- Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
- (2018) Jonathan G. Pol et al. OncoImmunology
- Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
- (2018) A Marabelle et al. ANNALS OF ONCOLOGY
- Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
- (2018) Carmela Passaro et al. CLINICAL CANCER RESEARCH
- Designing and building oncolytic viruses
- (2017) Justin Maroun et al. Future Virology
- Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins
- (2017) Nicolas Çuburu et al. INTERNATIONAL JOURNAL OF CANCER
- Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy
- (2017) Safieh Ebrahimi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of stromal cancer-associated fibroblasts in pancreatic cancer
- (2017) Dagny von Ahrens et al. Journal of Hematology & Oncology
- Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
- (2017) Nicholas M. Durham et al. MOLECULAR THERAPY
- Oncolytic Virotherapy: A Contest between Apples and Oranges
- (2017) Stephen J. Russell et al. MOLECULAR THERAPY
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs
- (2017) Michael C. Brown et al. Science Translational Medicine
- Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
- (2017) Dmitriy Zamarin et al. Nature Communications
- Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
- (2017) Pengju Wang et al. Nature Communications
- Predictors of responses to immune checkpoint blockade in advanced melanoma
- (2017) N. Jacquelot et al. Nature Communications
- Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
- (2017) Zuqiang Liu et al. Nature Communications
- How to develop viruses into anticancer weapons
- (2017) Roberto Cattaneo et al. PLoS Pathogens
- Prospects for combined use of oncolytic viruses and CAR T-cells
- (2017) Adam Ajina et al. Journal for ImmunoTherapy of Cancer
- Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
- (2017) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Monitoring the Efficacy of Oncolytic Viruses via Gene Expression
- (2017) Ashley Ansel et al. Frontiers in Oncology
- Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
- (2017) Daniel E. Meyers et al. Frontiers in Oncology
- Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery
- (2017) Dana Haddad Frontiers in Oncology
- Immune System, Friend or Foe of Oncolytic Virotherapy?
- (2017) Anna C. Filley et al. Frontiers in Oncology
- Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
- (2016) Praveen K. Bommareddy et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
- (2016) Robert H. I. Andtbacka et al. ANNALS OF SURGICAL ONCOLOGY
- Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
- (2016) Weizhou Hou et al. CANCER CELL
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- The cGAS-STING Defense Pathway and Its Counteraction by Viruses
- (2016) Zhe Ma et al. Cell Host & Microbe
- Mechanisms of viral mutation
- (2016) Rafael Sanjuán et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma
- (2016) Michelle J. Wilkinson et al. INTERNATIONAL JOURNAL OF CANCER
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus
- (2016) Rachel Myers et al. MOLECULAR THERAPY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
- (2016) Beatriz Vera et al. PLoS One
- Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy
- (2016) Stephanie Swift et al. Viruses-Basel
- Oncolytic viruses as immunotherapy: progress and remaining challenges
- (2016) Laure Aurelian OncoTargets and Therapy
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
- (2016) Eric Hastie et al. Oncotarget
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition
- (2016) Patricia Kleinpeter et al. OncoImmunology
- Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
- (2016) Eric Bartee et al. Molecular Therapy-Oncolytics
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study
- (2016) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing
- (2015) Y Terasawa et al. CANCER GENE THERAPY
- Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer
- (2015) L. Corrales et al. CLINICAL CANCER RESEARCH
- Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy
- (2015) Kevin J Harrington et al. Expert Review of Anticancer Therapy
- Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
- (2015) J Poutou et al. GENE THERAPY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
- (2015) Jo Marie Tran Janco et al. JOURNAL OF IMMUNOLOGY
- A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles
- (2015) Nicola Low et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Encoded Biomarkers for Monitoring Biological Therapies
- (2015) Desislava Tsoneva et al. PLoS One
- Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector
- (2015) Guido Wollmann et al. VIROLOGY
- Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
- (2015) Samantha Turnbull et al. Viruses-Basel
- Going viral: a review of replication-selective oncolytic adenoviruses
- (2015) Christopher Larson et al. Oncotarget
- Trial Watch—Oncolytic viruses and cancer therapy
- (2015) Jonathan Pol et al. OncoImmunology
- Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
- (2015) Ilkka Liikanen et al. OncoImmunology
- OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal
- (2015) Stefanie N. Linch et al. Frontiers in Oncology
- Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity
- (2015) Jun Li et al. NEOPLASIA
- Molecular imaging of oncolytic viral therapy
- (2015) Dana Haddad et al. Molecular Therapy-Oncolytics
- Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
- (2014) N. Nishio et al. CANCER RESEARCH
- Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
- (2014) E. Galanis et al. CANCER RESEARCH
- Aerosol gene delivery using viral vectors and cationic carriers forin vivolung cancer therapy
- (2014) Seong-Ho Hong et al. Expert Opinion on Drug Delivery
- Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma
- (2014) Tim D. Pencavel et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF
- (2014) Weizhou Hou et al. INTERNATIONAL JOURNAL OF CANCER
- Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses
- (2014) A. M. Chmielewska et al. JOURNAL OF VIROLOGY
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Safety and immunogenicity of dry powder measles vaccine administered by inhalation: A randomized controlled Phase I clinical trial
- (2014) Sharad Agarkhedkar et al. VACCINE
- Oncolytic Viruses and Their Application to Cancer Immunotherapy
- (2014) E. A. Chiocca et al. Cancer Immunology Research
- Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
- (2014) Andrew Zloza et al. Journal for ImmunoTherapy of Cancer
- Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model
- (2013) D Yin et al. CANCER GENE THERAPY
- Enhanced Tumor Uptake and Penetration of Virotherapy Using Polymer Stealthing and Focused Ultrasound
- (2013) Robert Carlisle et al. JNCI-Journal of the National Cancer Institute
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on oncolytic viral therapy – targeting angiogenesis
- (2013) James Tysome et al. OncoTargets and Therapy
- Pre-existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
- (2013) Vedell Louis Jeune et al. Human Gene Therapy Methods
- Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+T-cell responses to anticancer vaccines
- (2013) Byram W Bridle et al. OncoImmunology
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation
- (2011) S Yamada et al. CANCER GENE THERAPY
- A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy
- (2011) L Chai et al. CANCER GENE THERAPY
- Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus
- (2011) Phonphimon Wongthida et al. HUMAN GENE THERAPY
- Myeloma Xenograft Destruction by a Nonviral Vector Delivering Oncolytic Infectious Nucleic Acid
- (2011) Elizabeth M Hadac et al. MOLECULAR THERAPY
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
- (2011) Alan Melcher et al. MOLECULAR THERAPY
- MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism
- (2011) Mathias F Leber et al. MOLECULAR THERAPY
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT
- (2010) J C Doloff et al. CANCER GENE THERAPY
- Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- Impact of tumor microenvironment on oncolytic viral therapy
- (2010) Jeffrey Wojton et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?
- (2010) T Pencavel et al. GENE THERAPY
- Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
- (2010) Sunil K. Geevarghese et al. HUMAN GENE THERAPY
- Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing
- (2010) Fabrice Le Boeuf et al. MOLECULAR THERAPY
- Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific Immunotherapy
- (2010) Yu-Qian Zhang et al. MOLECULAR THERAPY
- Induction of type I interferon by RNA viruses: cellular receptors and their substrates
- (2009) Alina Baum et al. AMINO ACIDS
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy
- (2009) I-K Choi et al. GENE THERAPY
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
- Hypercostimulation through 4-1BB Distorts Homeostasis of Immune Cells
- (2009) S.-W. Lee et al. JOURNAL OF IMMUNOLOGY
- E4orf1 Limits the Oncolytic Potential of the E1B-55K Deletion Mutant Adenovirus
- (2009) M. A. Thomas et al. JOURNAL OF VIROLOGY
- Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice
- (2008) Y Kulu et al. CANCER GENE THERAPY
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models
- (2008) S. Ganesh et al. CLINICAL CANCER RESEARCH
- Factors influencing retention of adenovirus within tumours following direct intratumoural injection
- (2008) M Bazan-Peregrino et al. GENE THERAPY
- Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
- (2008) C L White et al. GENE THERAPY
- Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNA
- (2008) E. Ylosmaki et al. JOURNAL OF VIROLOGY
- Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide
- (2008) Mark A Currier et al. MOLECULAR THERAPY
- Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
- (2008) Adam Vigil et al. MOLECULAR THERAPY
- A let-7 MicroRNA-sensitive Vesicular Stomatitis Virus Demonstrates Tumor-specific Replication
- (2008) Robert E Edge et al. MOLECULAR THERAPY
- Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling
- (2008) Karen E. Johnson et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now